Clinical Trial Update: Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This update covers safety data from a Phase 1/2 immunomodulating microparticle studied for primary and secondary progressive multiple sclerosis. The trial spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Immunomodulating microparticle

Snippet

Sponsor: Innate Immunotherapeutics | Conditions: Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 1, Phase 2 | Status: COMPLETED